Ca2+ sensitivity of fetal coronary arteries exposed to long-term, high-altitude hypoxia

Journal of the Society for Gynecologic Investigation

Volumn 7, Issue 3, 2000, Pages 161-166

  Garcia, Felizabel C ^a   Stiffel, Virginia M ^a   Pearce, William J ^a   Zhang, Lubo ^a   Gilbert, Raymond D ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

escin; Ca2+ sensitivity; Intrauterine hypoxemia; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BETA ESCIN; CALCIMYCIN; CALCIUM ION; POTASSIUM; THROMBOXANE A2 DERIVATIVE;

ALTITUDE DISEASE; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; FETUS; FETUS HYPOXIA; HYPOXIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; SHEEP; VASCULAR RING;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ALTITUDE; ANIMALS; CALCIUM; CELL MEMBRANE PERMEABILITY; CORONARY VESSELS; ESCIN; FEMALE; FETAL HYPOXIA; MUSCLE CONTRACTION; POTASSIUM; PREGNANCY; SHEEP; VASOCONSTRICTOR AGENTS;

EID: 0034611812     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(00)00043-5     Document Type: Article

References (34)

1. Rembold C.M. Regulation of contraction and relaxation in arterial smooth muscle. Hypertension. 20:1992;129-137.
2. Somlyo A.P., Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature. 372:1994;231-236.
3. Akopov S., Zhang L., Pearce W.J. Physiological variations in ovine cerebrovascular calcium sensitivity. Am J Physiol. 272:1997;H2271-H2281.
4. 2+ release in smooth muscle. J Biol Chem. 264:1989;17997-18004.
5. 2+ of the smooth muscle contractile apparatus in the rat isolated femoral vein. Br J Pharmacol. 111:1994;978-980.
6. 2+-sensitization of coronary artery contraction in genetically hypertensive rats. J Clin Invest. 94:1994;1397-1403.
7. Ohlstein E.H., Kopia G.A., Zeid R.L., et al. Effects of the thromboxane receptor antagonist SK&F 88046 in the canine, monkey, and human vasculature. Prostaglandins. 36:1988;69-84.
8. 2+ uptake induced by the thromboxane mimetic U46619 in sheep coronary artery. Eur J Pharmacol. 270:1994;313-319.
9. Yamagishi T., Yanasigawa T., Satoh K., Taira N. Relaxant mechanisms of cyclic AMP-increasing agents in porcine coronary artery. Eur J Pharmacol. 251:1994;253-262.
10. Kamitomo M., Alonso J.G., Okai T., Longo L.D., Gilbert R.D. Effects of long-term, high-altitude hypoxemia on fetal ovine cardiac output and blood flow redistribution. Am J Obstet Gynecol. 169:1993;701-707.
11. 2+ sensitivity of rat, guinea pig, and frog ventricular muscle. Am J Physiol 1990;258:C274-81.
12. 2+ free media are mediated by different signal transduction pathways in rat aorta. Br J Pharmacol. 110:1993;875-881.
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260:1985;3440-3450.
14. 2+ sensitivity during muscarinic receptor stimulation of airway smooth muscle. Am J Physiol 1996;271:L719-25.
15. Savineau J.P., Marthan R. Activation properties of chemically skinned fibers from human isolated bronchial smooth muscle. J Physiol. 474:1994;433-438.
16. 2+ sensitivity in β-escin-skinned cardiac and vascular smooth muscles. Eur J Pharmacol. 326:1997;157-162.
17. Bruce L., Nixon G.F. Increased sensitization of the myofilaments in rat neonatal portal vein A potential mechanism . Exp Physiol. 82:1997;985-993.
18. 2+ during hypoxia in spontaneously active vascular smooth muscle in rats. Exp Physiol. 78:1993;395-402.
19. 2+ localization and sensitivity in vascular smooth muscle. Trends Pharmacol Sci. 10:1989;320-325.
20. Zhang L. Adaptation of pharmacomechanical coupling of vascular smooth muscle to chronic hypoxia. Comp Biochem Physiol. 119A:1998;661-667.
21. Hathaway D.R., March K.L., Lash J.A., Adam L.P., Wilensky R.L. Vascular smooth muscle A review of the molecular basis of contractility . Circulation. 83:1991;382-390.
22. Payne M.E., Elzinga M., Adelstein R. Smooth muscle myosin light chain kinase Amino acid sequence at the site phosphorylated by adenosine cyclic-3′,5′-phosphate dependent protein kinase whether or not calmodulin is bound . J Biol Chem. 259:1984;8429-8436.
23. Hathaway D.R., Konicki M.V., Coolican S.A. Phosphorylation of MLCK from VSM by cAMP and cGMP-dependent protein kinases. J Mol Cell Cardiol. 17:1985;841-850.
24. 2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem. 266:1991;1708-1715.
25. Hori M., Karaki H. Regulatory mechanisms of calcium sensitization of contractile elements in smooth muscle. Life Sci. 62:1998;1629-1633.
26. 2 receptors. J Biol Chem. 268:1993;26011-26017.
27. 2 alpha. J Pharmacol Exp Ther. 281:1997;957-964.
28. 2 stimulated signal transduction in vascular smooth muscle. J Pharmacol Exp Ther. 265:1992;447-456.
29. ++ concentration and tension in human umbilical artery. Am J Obstet Gynecol. 172:1995;1414-1421.
30. 2 receptor-mediated contraction in rat aorta. J Pharmacol Exp Ther. 284:1998;921-928.
31. Nishimura J., Khalil R.A., van Breemen C. Agonist-induced vascular tone. Hypertension. 6:1989;834-844.
32. Bradley A.B., Morgan K.G. Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin. J Physiol. 385:1987;437-448.
33. 2+ sensitivity in rabbit pulmonary artery smooth muscle. Pfluegers Arch. 417:1990;21-28.
34. 2 analogue, U-46619, potentiates calcium-activated force in human umbilical artery. Am J Physiol 1993;264:H1878-83.